Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2,3-diacylated, 2- and 3-mono-acylated alkylated imino sugars exhibiting glucosidase inhibition and their method of use

2,3-diacylated, 2- and 3-mono-acylated alkylated imino sugars exhibiting glucosidase inhibition and their method of use

US Patent 10421723 · Granted Sep 24, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Early detection of hepatocellular carcinoma2022
Substituted aminothiazoles2021
Diagnosis of liver pathology through assessment of protein glycosylation2020
Alkylated imino sugars exhibiting glucosidase inhibition and their method of use2019
Alkylated imino sugars exhibiting glucosidase inhibition and their method of use2019
Alkylated imino sugars exhibiting glucosidase inhibition and their method of use2019
Diagnosis of liver pathology through assessment of anti-gal IgG glycosylation2019
Modulation of hepatitis B virus cccDNA transcription2018
Modulation of hepatitis B virus cccDNA transcription2018
Substituted aminothiazoles as inhibitors of cancers, including hepatocellular ca2018
Diagnosis of liver pathology through assessment of protein glycosylation2018
Use of sting agonists to treat chronic hepatitis B virus infection2018